ALPELISIB, FULVESTRANT, ALPELISIB, LETROZOLE, LEUPRORELIN ACETATE, GOSERELIN
CBYL719X2402
Phase 2 small_molecule active
Quick answer
ALPELISIB, FULVESTRANT, ALPELISIB, LETROZOLE, LEUPRORELIN ACETATE, GOSERELIN for Adult patients with PIK3CA mutant, HR-positive, HER2-negative advanced breast cancer is a Phase 2 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Adult patients with PIK3CA mutant, HR-positive, HER2-negative advanced breast cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active